Login to Your Account


Pharma: Other News To Note


Friday, July 26, 2013

• Teva Pharmaceutical Industries Ltd., of Jerusalem, and Lonza Group, of Basel, Switzerland, said they decided to discontinue their collaboration for the development, manufacturing and marketing of biosimilars following a strategic review of the Teva-Lonza Joint Venture.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription


»